A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals

Cleide G da Silva1, Peter Studer, Marco Skroch

  • 1Division of Vascular and Endovascular Surgery, Center for Vascular Biology Research and the Transplant Institute, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Hepatology (Baltimore, Md.)
|December 15, 2012
PubMed
Abstract

Insights

A20 protein promotes liver regeneration by enhancing interleukin-6/signal transducer and activator of transcription 3 (IL-6/STAT3) signaling and reducing the cell cycle inhibitor p21. This suggests A20-based therapies could aid liver repair.

Area of Science:

  • Hepatology and regenerative medicine
  • Molecular biology and cell signaling
  • Inflammation and immunology

Background:

  • Liver regeneration is crucial for treating liver injury, resection, and transplantation.
  • A20 protein exhibits anti-inflammatory and NF-κB inhibitory functions.
  • A20 has known pro-proliferative effects on hepatocytes, partly via p21 regulation.

Purpose of the Study:

  • To elucidate the mechanisms by which A20 promotes hepatocyte proliferation.
  • To investigate the role of A20 in regulating IL-6/STAT3 signaling pathways.
  • To determine the functional domains of A20 involved in these processes.

Main Methods:

  • Investigated A20's effect on p21 expression and NF-κB activity.
  • Assessed A20's impact on IL-6-induced STAT3 phosphorylation via SOCS3 regulation.
  • Utilized A20 overexpression and knockdown models in mouse liver resection studies.
  • Analyzed microRNA (miR203) regulation of SOCS3.

Main Results:

  • A20's C-terminal domain (7Zn) is crucial for decreasing p21 and inhibiting NF-κB.
  • A20 enhances sustained IL-6/STAT3 phosphorylation by reducing SOCS3 expression, a mechanism mediated by the 7Zn domain.
  • A20 deficiency increases SOCS3, impairing IL-6/STAT3 signaling and potentially involving decreased miR203.
  • In vivo, A20 overexpression boosted pro-proliferative IL-6/STAT3 targets post-resection, while knockdown had the opposite effect.

Conclusions:

  • A20 promotes hepatocyte proliferation by down-regulating SOCS3, likely via miR203, thereby enhancing IL-6/STAT3 pro-proliferative signals.
  • A20's dual action—reducing p21 and boosting IL-6/STAT3 signaling—establishes its pro-proliferative role in hepatocytes.
  • These findings support the development of A20-based therapies for promoting liver regeneration and repair.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...